These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19576186)

  • 1. Mechanisms of anti-cancer action and pharmacology of clofarabine.
    Zhenchuk A; Lotfi K; Juliusson G; Albertioni F
    Biochem Pharmacol; 2009 Dec; 78(11):1351-9. PubMed ID: 19576186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofarabine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity.
    Lech-Maranda E; Korycka A; Robak T
    Mini Rev Med Chem; 2009 Jun; 9(7):805-12. PubMed ID: 19519505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clofarabine (2-chloro-2'-fluoro-2'-deoxyarabinosyladenine)--biochemical aspects of anticancer activity.
    Majda K; Lubecka K; Kaufman-Szymczyk A; Fabianowska-Majewska K
    Acta Pol Pharm; 2011; 68(4):459-66. PubMed ID: 21796927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofarabine: a new treatment option for patients with acute myeloid leukemia.
    Larson ML; Venugopal P
    Expert Opin Pharmacother; 2009 Jun; 10(8):1353-7. PubMed ID: 19463072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and development of clofarabine: a nucleoside analogue for treating cancer.
    Bonate PL; Arthaud L; Cantrell WR; Stephenson K; Secrist JA; Weitman S
    Nat Rev Drug Discov; 2006 Oct; 5(10):855-63. PubMed ID: 17016426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clofarabine: emerging role in leukemias.
    Sampat K; Kantarjian H; Borthakur G
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1559-64. PubMed ID: 19715446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.
    Faderl S; Gandhi V; Keating MJ; Jeha S; Plunkett W; Kantarjian HM
    Cancer; 2005 May; 103(10):1985-95. PubMed ID: 15803490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of clofarabine in acute myeloid leukemia.
    Ghanem H; Kantarjian H; Ohanian M; Jabbour E
    Leuk Lymphoma; 2013 Apr; 54(4):688-98. PubMed ID: 22957815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clofarabine on apoptosis and DNA synthesis in human epithelial colon cancer cells.
    Wang X; Albertioni F
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):414-8. PubMed ID: 20544529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine: past, present, and future.
    Kantarjian HM; Jeha S; Gandhi V; Wess M; Faderl S
    Leuk Lymphoma; 2007 Oct; 48(10):1922-30. PubMed ID: 17852710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofarabine in pediatric acute leukemia: current findings and issues.
    Hijiya N; Barry E; Arceci RJ
    Pediatr Blood Cancer; 2012 Sep; 59(3):417-22. PubMed ID: 22354543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofarabine in leukemia.
    Ghanem H; Jabbour E; Faderl S; Ghandhi V; Plunkett W; Kantarjian H
    Expert Rev Hematol; 2010 Feb; 3(1):15-22. PubMed ID: 21082931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofarabine in the treatment of myelodysplastic syndromes.
    Bryan J; Kantarjian H; Prescott H; Jabbour E
    Expert Opin Investig Drugs; 2014 Feb; 23(2):255-63. PubMed ID: 24410313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow CFU-GM and human tumor xenograft efficacy of three antitumor nucleoside analogs.
    Bagley RG; Roth S; Kurtzberg LS; Rouleau C; Yao M; Crawford J; Krumbholz R; Lovett D; Schmid S; Teicher BA
    Int J Oncol; 2009 May; 34(5):1329-40. PubMed ID: 19360345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clofarabine for myelodysplastic syndromes.
    Tiu RV; Traina F; Sekeres MA
    Expert Opin Investig Drugs; 2011 Jul; 20(7):1005-14. PubMed ID: 21591997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
    Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel purine nucleoside analogues for hematological malignancies.
    Korycka A; Lech-Marańda E; Robak T
    Recent Pat Anticancer Drug Discov; 2008 Jun; 3(2):123-36. PubMed ID: 18537755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofarabine and nelarabine: two new purine nucleoside analogs.
    Gandhi V; Plunkett W
    Curr Opin Oncol; 2006 Nov; 18(6):584-90. PubMed ID: 16988579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.
    Cooper T; Kantarjian H; Plunkett W; Gandhi V
    Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1417-23. PubMed ID: 15571270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three new drugs for acute lymphoblastic leukemia: nelarabine, clofarabine, and forodesine.
    Larson RA
    Semin Oncol; 2007 Dec; 34(6 Suppl 5):S13-20. PubMed ID: 18086342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.